JP2021515755A5 - - Google Patents

Info

Publication number
JP2021515755A5
JP2021515755A5 JP2020545154A JP2020545154A JP2021515755A5 JP 2021515755 A5 JP2021515755 A5 JP 2021515755A5 JP 2020545154 A JP2020545154 A JP 2020545154A JP 2020545154 A JP2020545154 A JP 2020545154A JP 2021515755 A5 JP2021515755 A5 JP 2021515755A5
Authority
JP
Japan
Prior art keywords
compound
salt according
salt
formula
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020545154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021515755A (ja
JP7251893B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/051510 external-priority patent/WO2019166937A1/en
Publication of JP2021515755A publication Critical patent/JP2021515755A/ja
Publication of JP2021515755A5 publication Critical patent/JP2021515755A5/ja
Application granted granted Critical
Publication of JP7251893B2 publication Critical patent/JP7251893B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020545154A 2018-02-28 2019-02-25 N-1分枝基を有する置換イミダゾ[4,5-c]キノリン化合物 Active JP7251893B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862636367P 2018-02-28 2018-02-28
US62/636,367 2018-02-28
PCT/IB2019/051510 WO2019166937A1 (en) 2018-02-28 2019-02-25 Substituted imidazo[4,5-c]quinoline compounds with an n-1 branched group

Publications (3)

Publication Number Publication Date
JP2021515755A JP2021515755A (ja) 2021-06-24
JP2021515755A5 true JP2021515755A5 (cg-RX-API-DMAC7.html) 2022-03-04
JP7251893B2 JP7251893B2 (ja) 2023-04-04

Family

ID=65904502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020545154A Active JP7251893B2 (ja) 2018-02-28 2019-02-25 N-1分枝基を有する置換イミダゾ[4,5-c]キノリン化合物

Country Status (7)

Country Link
US (1) US11370788B2 (cg-RX-API-DMAC7.html)
EP (1) EP3759107B1 (cg-RX-API-DMAC7.html)
JP (1) JP7251893B2 (cg-RX-API-DMAC7.html)
CN (1) CN111788202B (cg-RX-API-DMAC7.html)
CA (1) CA3092545A1 (cg-RX-API-DMAC7.html)
ES (1) ES3003782T3 (cg-RX-API-DMAC7.html)
WO (1) WO2019166937A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220194935A1 (en) * 2019-06-12 2022-06-23 3M Innovative Properties Company Phenethyl substituted imidazo[4,5-c]quinoline compounds with an n-1 branched group
WO2022008995A1 (en) 2020-07-08 2022-01-13 3M Innovative Properties Company N-1 branched imidazoquinolines, conjugates thereof, and methods
CN116635394A (zh) * 2020-12-16 2023-08-22 3M创新有限公司 N-1支化咪唑并喹啉、其缀合物和方法
WO2022130046A1 (en) 2020-12-16 2022-06-23 3M Innovative Properties Company N-1 branched imidazoquinolines, conjugates thereof, and methods
CN118401523A (zh) * 2021-12-14 2024-07-26 舒万诺知识产权公司 N-1三唑取代的咪唑并喹啉、其缀合物和方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700674A (en) 1969-04-30 1972-10-24 American Cyanamid Co 4-alkylamino-3-nitroquinolines
IL73534A (en) 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
US5389640A (en) 1991-03-01 1995-02-14 Minnesota Mining And Manufacturing Company 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
DK0708772T3 (da) 1993-07-15 2000-09-18 Minnesota Mining & Mfg Imidazo[4,5,-c]pyridin-4-aminer
US5352784A (en) 1993-07-15 1994-10-04 Minnesota Mining And Manufacturing Company Fused cycloalkylimidazopyridines
JP4391592B2 (ja) 1996-10-25 2009-12-24 スリーエム カンパニー Th2介在性および関連疾患治療のための免疫応答修飾化合物
JPH1180156A (ja) 1997-09-04 1999-03-26 Hokuriku Seiyaku Co Ltd 1−(置換アリール)アルキル−1h−イミダゾピリジン−4−アミン誘導体
UA67760C2 (uk) 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6110929A (en) 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
US6451810B1 (en) 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
UA74852C2 (en) * 2000-12-08 2006-02-15 3M Innovative Properties Co Urea-substituted imidazoquinoline ethers
US6677348B2 (en) 2000-12-08 2004-01-13 3M Innovative Properties Company Aryl ether substituted imidazoquinolines
US6677347B2 (en) * 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
AU2004229478B2 (en) 2003-04-10 2009-12-24 3M Innovative Properties Company Delivery of immune response modifier compounds
WO2005018556A2 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AR046781A1 (es) 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
WO2005066170A1 (en) * 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
AU2005228150A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US8541438B2 (en) 2004-06-18 2013-09-24 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
EP1765348B1 (en) * 2004-06-18 2016-08-03 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
EP1831226B1 (en) * 2004-12-30 2012-08-08 3M Innovative Properties Company Chiral tetracyclic compounds inducing interferon biosynthesis
ES2429170T3 (es) 2005-11-04 2013-11-13 3M Innovative Properties Company 1H-Imidazoquinolinas sustituidas con hidroxilo y alcoxilo y métodos
DK2606047T3 (en) 2010-08-17 2017-03-27 3M Innovative Properties Co COMPOSITIONS AND FORMULATIONS WITH LIPIDIZED IMMUNE RESPONSE-MODIFIING COMPOUND AND PROCEDURES THEREOF
US9034336B2 (en) 2011-08-30 2015-05-19 Regents Of The University Of Minnesota Immunomodulators and immunomodulator conjugates
ES2804101T3 (es) 2014-04-22 2021-02-03 Hoffmann La Roche Compuestos de 4-amino-imidazoquinolina
US10730871B2 (en) * 2016-01-28 2020-08-04 Regents Of The University Of Minnesota Immunomodulators and immunomodulator conjugates
CA3086439A1 (en) 2017-12-20 2019-06-27 3M Innovative Properties Company Amide substitued imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier
EP3887369B1 (en) 2018-11-26 2024-05-08 Solventum Intellectual Properties Company N-1 branched alkyl ether substituted imidazo[4,5-c]quinoline compounds, compositions, and methods

Similar Documents

Publication Publication Date Title
JP2021530451A5 (cg-RX-API-DMAC7.html)
JP2024514837A5 (cg-RX-API-DMAC7.html)
JP2012532883A5 (cg-RX-API-DMAC7.html)
JP2015512946A5 (cg-RX-API-DMAC7.html)
JP2010527913A5 (cg-RX-API-DMAC7.html)
JP2016503793A5 (cg-RX-API-DMAC7.html)
JP2013503846A5 (cg-RX-API-DMAC7.html)
JP2004516314A5 (cg-RX-API-DMAC7.html)
CA2503884A1 (en) Cyclic sulfamides for inhibition of gamma-secretase
AR049446A1 (es) Preparacion de pregabalina ((s)-(+)-aminometil-5-metilhexanoico) y compuestos relacionados
MX2010008468A (es) Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante.
JP2010519270A5 (cg-RX-API-DMAC7.html)
JP2016515561A5 (cg-RX-API-DMAC7.html)
AR040661A1 (es) Diclorhidrato cristalino de n-{2-[-((r)-2-hidroxi-2-feniletilamino)fenil]etil}-(r)-2hidroxi-2-(3-formamido-4-hidroxifenil)etilamina, agonista del receptor adrenergico beta 2
JP2009535358A5 (cg-RX-API-DMAC7.html)
JP2002513793A5 (cg-RX-API-DMAC7.html)
JP2012512863A5 (cg-RX-API-DMAC7.html)
JP2020500916A5 (cg-RX-API-DMAC7.html)
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2014500861A5 (cg-RX-API-DMAC7.html)
JP2017535610A5 (cg-RX-API-DMAC7.html)
JP2012513416A5 (cg-RX-API-DMAC7.html)
CA2744756A1 (en) Monocarbams and their use as antibacterial agent
JP2021528421A5 (cg-RX-API-DMAC7.html)
JP2013513607A5 (cg-RX-API-DMAC7.html)